<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488200</url>
  </required_header>
  <id_info>
    <org_study_id>CRU ID 15002474</org_study_id>
    <nct_id>NCT02488200</nct_id>
  </id_info>
  <brief_title>Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis</brief_title>
  <acronym>Peridialysis</acronym>
  <official_title>Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Holbaek Sygehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Jutland Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sonderborg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Skovde Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pauls Stradins Clinical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tartu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Hospital of Vestfold</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study plans to delineate the clinical, biochemical, sociological and&#xD;
      psychological factors. involved in dialysis preparation, and their impact on dialysis&#xD;
      initiation (DI), modality choice and prognosis. In particular the following questions are to&#xD;
      be answered.&#xD;
&#xD;
        1. What factors influence unplanned DI?&#xD;
&#xD;
        2. What factors influence choice of dialysis modality?&#xD;
&#xD;
        3. What factors influence choice of dialysis access?&#xD;
&#xD;
        4. Why do physicians start dialysis?&#xD;
&#xD;
        5. What factors in the predialytic period and its immediate aftermath (the &quot;peridialytic&quot;&#xD;
           period) influence prognosis?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients All patients starting active end stage renal disease (ESRD) treatment at the&#xD;
      participating centres and their satellite centres.&#xD;
&#xD;
      No. Patients: 1000.&#xD;
&#xD;
        1. Patients who have received their recent predialysis care at another centre can be&#xD;
           included if the previous centre's notes are available, otherwise not.&#xD;
&#xD;
        2. Patients receiving a preemptive transplant are included, even if the transplant is&#xD;
           performed at another centre. A patient questionnaire is not required for these patients.&#xD;
&#xD;
        3. Africans are excluded (inaccurate estimated glomerular filtration rate (eGFR)&#xD;
           calculation) Each patient is allocated a local identity number (1,2,3â€¦.). The local&#xD;
           author keeps a registry of the true patient identity of each identity number for&#xD;
           follow-up purposes. This registry is not to be used in any communication outside the&#xD;
           centre.&#xD;
&#xD;
      Comment: Most patients have known chronic uremia at dialysis start. In a few cases, it is&#xD;
      unknown whether the uremia is acute or chronic. There are two main groups:&#xD;
&#xD;
        1. Acute uremia of unknown origin. Doctors should fill the questionnaire in Table 2, which&#xD;
           can be discarded if the patient recovers renal function within three months.&#xD;
&#xD;
        2. Acute kidney injury (AKI). Most of these patients will recover within three months, so&#xD;
           the questionnaire can wait, and be filled in retrospectively for the few remaining&#xD;
           patients.&#xD;
&#xD;
      Methods&#xD;
&#xD;
        1. Each participating centre fills a Centre Questionnaire, see Table 1.&#xD;
&#xD;
        2. All prescribing doctors fill in a voluntary Physician Questionnaire, see Table 4.&#xD;
&#xD;
        3. The doctor prescribing the first dialysis fills in a Motivation Questionnaire, see Table&#xD;
           2.&#xD;
&#xD;
        4. The local coordinator fills in a Patient Notes Review&#xD;
&#xD;
             1. Birthday&#xD;
&#xD;
             2. Sex&#xD;
&#xD;
             3. Height and weight&#xD;
&#xD;
             4. Renal diagnosis&#xD;
&#xD;
             5. Comorbidity&#xD;
&#xD;
             6. Date and creatinine at referral to nephrology dept.&#xD;
&#xD;
             7. Date and creatinine 6 months before dialysis start&#xD;
&#xD;
             8. Date and creatinine 3 months before dialysis start&#xD;
&#xD;
             9. Date and creatinine at start of dialysis information/choice&#xD;
&#xD;
            10. Date and creatinine at access prescription. Date and creatinine at access creation.&#xD;
                If there are several attempts at access creation, the last attempt is registered.&#xD;
                For unplanned dialysis start, this is often the same date as dialysis start.&#xD;
&#xD;
            11. Date of dialysis start&#xD;
&#xD;
            12. Following values before first dialysis: B-hemoglobin, p- creatinine, urea,&#xD;
                potassium, calcium, phosphate, bicarbonate, albumin&#xD;
&#xD;
            13. Initial dialysis modality (centre hemodialysis (HD)/Home HD/continuous ambulatory&#xD;
                peritoneal dialysis (CAPD)/ automated peritoneal dialysis (APD))&#xD;
&#xD;
            14. Type of start (Planned/unplanned)&#xD;
&#xD;
            15. Reason for unplanned start (primary and (if appropriate) secondary).&#xD;
&#xD;
            16. For hemodialysis patient (HD) patients, initial access (areteriovenous fisula&#xD;
                (AVF)/arteriovenous graft (AVG) /tunneled central venous catheter (CVC)/temporary&#xD;
                CVC)&#xD;
&#xD;
            17. Modality after 3 months (Center HD/Home HD/CAPD/APD/regained&#xD;
                function/Transplanted/Dead)&#xD;
&#xD;
            18. Is the patient alive after 3 months Yes/No. If &quot;No&quot; Date of death.&#xD;
&#xD;
            19. Is the patient alive after 6 months Yes/No.&#xD;
&#xD;
            20. If &quot;No&quot; Date of death.Is the patient alive after 12 months Yes/No. If &quot;No&quot; Date of&#xD;
                death.&#xD;
&#xD;
            21. Was the patient transplanted after inclusion? If so, when?&#xD;
&#xD;
      Responsibilities National coordinators are responsible for translation of protocol to local&#xD;
      language, and compliance with any necessary national regulatory requirements (data protection&#xD;
      agency, ethical committee?) Local representatives: local coordination and follow-up. Patient&#xD;
      notes review. Additional secretarial assistance, paid or unpaid, is permitted.&#xD;
&#xD;
      Definitions&#xD;
&#xD;
      ESRD&#xD;
&#xD;
      A patient has ESRD if any of the following:&#xD;
&#xD;
        1. He receives a transplant&#xD;
&#xD;
        2. The doctor &quot;believes&quot; that he has ESRD at first dialysis&#xD;
&#xD;
        3. He has received &gt;90 days dialysis&#xD;
&#xD;
        4. If the doctor is in doubt whether the patient has acute or chronic renal failure, the&#xD;
           patient is registered as soon as there is no doubt that the patient has ESRD For 3 &amp; 4,&#xD;
           registration is performed retrospectively from the first dialysis day.&#xD;
&#xD;
      Planned dialysis&#xD;
&#xD;
      The patient's first dialysis is planned if:&#xD;
&#xD;
        1. His first hemodialysis uses an AV fistula&#xD;
&#xD;
        2. His first hemodialysis uses a permanent catheter as the patient's permanent access&#xD;
&#xD;
        3. His first peritoneal dialysis is &gt;6 days after catheter placement.&#xD;
&#xD;
      The patient's first dialysis is unplanned if:&#xD;
&#xD;
        1. His first hemodialysis uses a temporary catheter&#xD;
&#xD;
        2. His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e.&#xD;
           a later AV fistula is planned.&#xD;
&#xD;
        3. His first peritoneal dialysis is &lt;7 days after catheter placement.&#xD;
&#xD;
      Renal Diagnoses&#xD;
&#xD;
        1. Shrunken Kidneys of unknown cause&#xD;
&#xD;
        2. Glomerulonephritis&#xD;
&#xD;
        3. Chronic interstitial nephropathy, chronic pyelonephritis and postrenal uremia&#xD;
&#xD;
        4. Polycystic kidney disease&#xD;
&#xD;
        5. Hypertensive/atherosclerotic renal disease&#xD;
&#xD;
        6. Diabetic Nephropathy&#xD;
&#xD;
        7. Other&#xD;
&#xD;
      Causes of unplanned dialysis&#xD;
&#xD;
        1. Late referral&#xD;
&#xD;
        2. Acute uremia&#xD;
&#xD;
        3. Acute progression of chronic uremia&#xD;
&#xD;
        4. Doubt about reversibility&#xD;
&#xD;
        5. Clinical indication despite acceptable biochemistry&#xD;
&#xD;
        6. Fistula problems&#xD;
&#xD;
        7. Delayed planning (Controversial. I recommend dialysis planning at the latest when eGFR&#xD;
           &lt;15 ml/minute. Please use your own definition).&#xD;
&#xD;
        8. Patient non-compliance&#xD;
&#xD;
        9. Patient refused dialysis, but later changed his/her mind&#xD;
&#xD;
      Causes of PD modality&#xD;
&#xD;
        1. Patient choice&#xD;
&#xD;
        2. Cardiac insufficiency&#xD;
&#xD;
        3. HD not possible&#xD;
&#xD;
      Causes of HD Modality&#xD;
&#xD;
        1. Patient Choice&#xD;
&#xD;
        2. Physically incapable of peritoneal dialysis (PD)&#xD;
&#xD;
        3. Mentally incapable of PD&#xD;
&#xD;
        4. Abdominal problems&#xD;
&#xD;
        5. Wish for Home HD&#xD;
&#xD;
        6. PD not considered&#xD;
&#xD;
      Table 1 Center Questionnaire&#xD;
&#xD;
        1. Author:&#xD;
&#xD;
        2. Centre Name:&#xD;
&#xD;
        3. Centre type: University/Non-academic&#xD;
&#xD;
        4. Approximate population covered:&#xD;
&#xD;
        5. No. new ESRD patients/year&#xD;
&#xD;
        6. How many of these&#xD;
&#xD;
             1. Preemptive transplant (%)?&#xD;
&#xD;
             2. PD (%)?&#xD;
&#xD;
             3. HD (%)?&#xD;
&#xD;
        7. What is the&#xD;
&#xD;
             1. PD prevalence (no. patients)?&#xD;
&#xD;
             2. HD prevalence?&#xD;
&#xD;
        8. How many nephrology specialists?&#xD;
&#xD;
        9. Does the department have an official policy concerning preferred initial modality:&#xD;
&#xD;
             1. No&#xD;
&#xD;
             2. PD first&#xD;
&#xD;
             3. Home HD first&#xD;
&#xD;
             4. Other (what?)&#xD;
&#xD;
       10. Does the department have an official policy concerning when pretransplant investigations&#xD;
           should be initiated? If so what? If not, is there unofficial consensus? What?&#xD;
&#xD;
       11. Does the department have an official policy concerning when dialysis modality choice is&#xD;
           made? If so what? If not, is there unofficial consensus? What?&#xD;
&#xD;
       12. Does the department have an official policy concerning when AV fistulae/grafts are&#xD;
           prescribed? If so what? If not, is there unofficial consensus? What?&#xD;
&#xD;
       13. Does the department have an official policy concerning when peritoneal dialysis&#xD;
           catheters are prescribed? If so what? If not, is there unofficial consensus? What?&#xD;
&#xD;
       14. Does the department have an official policy concerning when chronic dialysis is&#xD;
           prescribed? If so what? If not, is there unofficial consensus? What?&#xD;
&#xD;
      Table 2. Motivation Questionnaire&#xD;
&#xD;
      You have just prescribed this patient's first dialysis. If you do not believe that the&#xD;
      patient's dialysis requirement is chronic, you do not have to fill in this form Put a &quot;1&quot;&#xD;
      besides the primary reason for starting dialysis today. Put a &quot;2&quot; besides a (possible)&#xD;
      secondary reason for starting dialysis today. Put a &quot;X&quot; besides any other reasons that have&#xD;
      been important in influencing your decision to prescribe dialysis today.&#xD;
&#xD;
      Taste disturbances Pulmonary stasis Social (what?) Dyspnea Practical (what?) (e.g. catheter&#xD;
      protection) Hypertension Pericarditis Oedema Biochemical Cardiac symptoms High&#xD;
      Plasma-Creatinine Fatigue High Urea Anorexia Low glomerular filtration rate (GFR)&#xD;
      Nausea/vomiting High Potassium Cachexia/weight loss Acidosis Itching Low calcium Insomnia&#xD;
      High Calcium Depression High Phosphate Diarrhea Falling GFR Other (what?)&#xD;
&#xD;
      Table 4. Physician Questionnaire What is your age? What is your sex? Are you a nephrology&#xD;
      specialist? How many years have you been a doctor? How many years have you been a nephrology&#xD;
      specialist?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Proportion of patients who start planned dialysis initiation as defined by the protocol</measure>
    <time_frame>1 year</time_frame>
    <description>Planned dialysis&#xD;
The patient's first dialysis is planned if:&#xD;
His first hemodialysis uses an AV fistula&#xD;
His first hemodialysis uses a permanent catheter as the patient's permanent access&#xD;
His first peritoneal dialysis is &gt;6 days after catheter placement.&#xD;
The patient's first dialysis is unplanned if:&#xD;
His first hemodialysis uses a temporary catheter&#xD;
His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.&#xD;
His first peritoneal dialysis is &lt;7 days after catheter placement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>1 year</time_frame>
    <description>Time to patient death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choice of dialysis modality</measure>
    <time_frame>1 year</time_frame>
    <description>Centre HD, Home HD, CAPD or APD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choice of dialysis access</measure>
    <time_frame>1 year</time_frame>
    <description>AVF, AVG, Temporary CVC, Tunneled CVC, or PD catheter</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>End Stage Renal Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Chronic Kidney Disease Stage 5 WHO start dialysis therapy for ESRD&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients starting maintenance dialysis therapies at the participating centers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Africans&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James G Heaf, MD DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herlev Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James G Heaf, MD DMSc</last_name>
    <phone>+4535125361</phone>
    <email>heaf@dadlnet.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James G Heaf, MD DMSc</last_name>
      <phone>+4535125361</phone>
      <email>heaf@dadlnet.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>June 13, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herlev Hospital</investigator_affiliation>
    <investigator_full_name>James heaf</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

